These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 62689)

  • 1. [Primary combined chemotherapy following removal of an endodermal sinus tumor or yolk-sac tumor of the ovary (author's transl)].
    Frick R; Rummel H; Wurster K; Kaufmann M
    Geburtshilfe Frauenheilkd; 1976 Nov; 36(11):946-50. PubMed ID: 62689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endodermal sinus tumor (yolk sac tumor), seminoma and hemangiopericytoma. Rare primary mediastinal tumors. A report on the course of the disease in nine patients.
    Dittler HJ; Mack D; Steuer G
    Thorac Cardiovasc Surg; 1980 Aug; 28(4):259-64. PubMed ID: 6158129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transformation of ovarian yolk sac tumor to immature teratoma following chemotherapy].
    Ihara T; Hisamatsu K; Okamoto E; Suemitsu H; Yamada M; Matsuda M; Nanba K; Kirimoto K
    Gan No Rinsho; 1985 May; 31(5):576-81. PubMed ID: 2410638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yolk sac tumor of the ovary during pregnancy: a case report.
    Aoki Y; Higashino M; Ishii S; Tanaka K
    Gynecol Oncol; 2005 Nov; 99(2):497-9. PubMed ID: 16051324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysgerminoma: the role of conservative surgery.
    Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
    Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dysgerminomas. Clinical aspects, therapy and prognosis with reference to the cooperative therapy study MAIKEI 83/86 for non-testicular germ cell tumors of the Society of Pediatric Oncology].
    Göbel U; Bamberg M; Calaminus G; Jürgens H; Pelzer V; Simon WE; Terruhn V; Wolf A; Mecke H; Harms D
    Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):737-42. PubMed ID: 2792708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yolk sac tumor in a young girl: a case report.
    Razzi S; Luisi S; Gabbanini M; Lazzeri L; Mazzini M; Petraglia F
    Gynecol Endocrinol; 2005 Jun; 20(6):334-5. PubMed ID: 16019383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of ovarian dysgerminoma to yolk sac tumor: evidence for a histogenetic continuum.
    Parkash V; Carcangiu ML
    Mod Pathol; 1995 Oct; 8(8):881-7. PubMed ID: 8552580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype.
    Obata NH; Nakashima N; Kawai M; Kikkawa F; Mamba S; Tomoda Y
    Gynecol Oncol; 1995 Jul; 58(1):124-8. PubMed ID: 7789879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clear cell carcinoma of the ovary simulating a yolk sac tumor].
    Bahri I; Boudawara T; Khabir A; Beyrouti MI; Frikha M; Jlidi R
    Ann Pathol; 2003 Apr; 23(2):165-8. PubMed ID: 12843973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endodermal sinus tumor of the ovary associated with pregnancy.
    Malone JM; Gershenson DM; Creasy RK; Kavanagh JJ; Silva EG; Stringer CA
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):86S-89S. PubMed ID: 2426643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
    Tran TA; Ortiz HB; Holloway RW; Bigsby GE; Finkler NJ
    Int J Gynecol Pathol; 2007 Jan; 26(1):66-70. PubMed ID: 17197899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
    Ballas M
    Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
    Kommoss F; Schmidt M; Merz E; Knapstein PG; Young RH; Scully RE
    Gynecol Oncol; 1999 Mar; 72(3):421-4. PubMed ID: 10053117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.